{
    "clinical_study": {
        "@rank": "13108", 
        "arm_group": [
            {
                "arm_group_label": "d-cycloserine", 
                "arm_group_type": "Experimental", 
                "description": "oral, capsule, 250 mg, once"
            }, 
            {
                "arm_group_label": "sugar pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "oral, capsule, once"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether d-cycloserine augments the clinical\n      effects of exposure-based cognitive-behaviour therapy for panic disorder."
        }, 
        "brief_title": "D-cycloserine Augmented CBT for Panic Disorder", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Panic Disorder", 
        "condition_browse": {
            "mesh_term": "Panic Disorder"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  clinical diagnosis of panic disorder\n\n          -  at least moderate agoraphobic avoidance\n\n        Exclusion Criteria:\n\n          -  psychoactive medication last 6 weeks\n\n          -  exposure-based cognitive-behaviour treatment for panic disorder and agoraphobia\n             during last 3 months\n\n          -  female participant who is pregnant or breast-feeding\n\n          -  lifetime history of psychosis, bipolar disorder, alcohol, medication or drug abuse or\n             dependence; current primary depressive disorder\n\n          -  lifetime history of epilepsy or other significant disease or disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01680107", 
            "org_study_id": "MRC-01", 
            "secondary_id": "2012-003191-39"
        }, 
        "intervention": [
            {
                "arm_group_label": "d-cycloserine", 
                "intervention_name": "d-cycloserine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "sugar pill", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "d-cycloserine", 
                    "sugar pill"
                ], 
                "intervention_name": "cognitive-behaviour therapy", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Cycloserine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "d-cycloserine, cognitive-behaviour therapy, panic disorder", 
        "lastchanged_date": "June 19, 2013", 
        "location": {
            "contact": {
                "email": "andrea.reinecke@psych.ox.ac.uk", 
                "last_name": "Andrea Reinecke, PhD", 
                "phone": "+44 (0)1865 226471"
            }, 
            "facility": {
                "address": {
                    "city": "Oxford", 
                    "country": "United Kingdom", 
                    "zip": "OX37JX"
                }, 
                "name": "Department of Psychiatry, University of Oxford"
            }, 
            "investigator": {
                "last_name": "Andrea Reinecke, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of a Single-dose of D-cycloserine on the Basic Effects of Cognitive-behaviour Therapy for Panic Disorder - a Randomized Placebo-controlled Trial", 
        "overall_contact": {
            "email": "andrea.reinecke@psych.ox.ac.uk", 
            "last_name": "Andrea Reinecke, PhD", 
            "phone": "+44 (0)1865 226471"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Oxford", 
                "last_name": "Andrea Reinecke, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Oxford", 
                "last_name": "Catherine Harmer, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "self-reported and clinician-rated anxiety and depression measures", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01680107"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "emotional information processing", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "University of Oxford", 
        "sponsors": {
            "collaborator": {
                "agency": "Medical Research Council", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Oxford", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}